No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading ...

Medtronic plc is rated a Buy, expecting 10-11% annual total returns, supported by 7-8% EPS growth. Learn more about MDT stock ...

The stock's rise snapped a three-day losing streak.

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

This device will take time to have a material impact on the company's financial results. Still, Medtronic has a strong business, multiple growth opportunities, and a fantastic dividend program. 10 ...

Medtronic's fair value estimate has nudged higher to $111.05 from $109.82 as analysts grow more confident that the company ...

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Medtronic (MDT) has quietly outperformed the broader healthcare space over the past year, and that steady climb is getting investors to revisit whether this long standing medical device leader still ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Symbiosis International University, through its Symbiosis Centre for Health Skills (SCHS), has partnered with Medtronic to ...

In Medtronic’s case specifically, the EY authors write, the company reported that its ability to predict and modulate supply ...